Finance

Lists
Why is IVVD down 3.76%?
Dive Deeper
IVVD:NASDAQ
Invivyd Inc
$0.56
-3.76%
(-0.022) 1D
$0.59
+4.00% (+0.022)
After hours
Closed: Nov 6, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IVVD...
Open
$0.59
High
$0.60
Low
$0.56
Mkt. cap
164.54M
Avg. vol.
5.95M
Volume
2.34M
52-wk high
$3.07
52-wk low
$0.53
EPS
-$0.37
Beta
1.20
Shares outstanding
294.76M
No. of employees
122
Open
$0.59
High
$0.60
Low
$0.56
Mkt. cap
164.54M
Avg. vol.
5.95M
Volume
2.34M
52-wk high
$3.07
52-wk low
$0.53
EPS
-$0.37
Beta
1.20
Shares outstanding
294.76M
No. of employees
122
News stories
From web sources and news partners
About Invivyd Inc
CEO-
Employees122
Founded2020
HeadquartersNew Haven, Connecticut, United States
SectorHealth Care
IndustryBiotechnology
Websiteinvivyd.com
Analyst ratings
Based on 3 analysts giving stock ratings to IVVD in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for IVVD in the last 3 months.
Highest
Current $0.56
$10.00 (+1,676.20%)
Average
$10.00 (+1,676.20%)
Lowest
$10.00 (+1,676.20%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Shrader
BTIG
Buy
Maintained
$10.00
+1,676.2%
09/29/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
$10.00
+1,676.2%
09/30/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
$10.00
+1,676.2%
09/01/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
13.13M
17.21M
13.74M
14.28M
Cost of goods sold
1.09M
1.14M
1.03M
1.27M
Cost of revenue
1.09M
1.14M
1.03M
1.27M
Research and development expenses
8.05M
10.05M
30.73M
29.37M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.02M
18.57M
25.12M
29.46M
Operating expense
23.06M
28.62M
55.85M
58.83M
Total operating expenses
24.15M
29.76M
56.88M
60.10M
Operating income
-11.02M
-12.56M
-43.14M
-45.82M
Other non operating income
-1.00K
-35.00K
-7.00K
-76.00K
EBT including unusual items
-10.47M
-11.07M
-41.40M
-44.39M
EBT excluding unusual items
-10.47M
-11.07M
-41.40M
-44.39M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.47M
-11.07M
-41.40M
-44.39M
Net profit margin
-79.75%
-64.33%
-301.22%
-310.77%
Earnings per share
-0.06
-
-0.13
-0.14
Interest and investment income
554.00K
1.52M
1.74M
1.50M
Interest expense
-
-
-
-
Net interest expenses
554.00K
1.52M
1.74M
1.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.87M
-12.41M
-42.97M
-45.64M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps